Trevi Therapeutics
TRVI
#4507
Rank
A$3.66 B
Marketcap
A$25.83
Share price
1.82%
Change (1 day)
184.61%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2025 (TTM): -A$65.64 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. , an increase over its 2024 earnings that were of -A$69.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -A$61.7 Million-10.67%
2024 -A$69.07 Million67%
2023 -A$41.36 Million2.43%
2022 -A$40.38 Million-14.45%
2021 -A$47.2 Million1.36%
2020 -A$46.57 Million23.64%
2019 -A$37.67 Million27.54%
2018 -A$29.53 Million